Page last updated: 2024-12-07
cl 88236
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
CL 88236: RN given refers to parent cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 135010 |
| SCHEMBL ID | 2599287 |
| MeSH ID | M0054664 |
Synonyms (33)
| Synonym |
|---|
| 34839-13-9 |
| 6h2e3oxb13 , |
| 1-amino-3-chloro-2-propanol hydrochloride, (s)- |
| unii-6h2e3oxb13 |
| (s)-1-amino-3-chloro-2-propanol hydrochloride |
| 2-propanol, 1-amino-3-chloro-, hydrochloride, (s)- |
| cl 88236 |
| (-)-1-amino-3-chloro-2-propanol hydrochloride |
| (2s)-1-amino-3-chloropropan-2-ol hydrochloride |
| AKOS016011935 |
| (s)-1-amino-3-chloropropan-2-ol hydrochloride |
| (2s)-1-amino-3-chloro-2-propanol hydrochloride |
| ZCPJBHYNOFIAPJ-AENDTGMFSA-N |
| SCHEMBL2599287 |
| J-502361 |
| 2-propanol, 1-amino-3-chloro-, hydrochloride, (2s)- |
| AC-26415 |
| mfcd09056870 |
| 2-propanol, 1-amino-3-chloro-, hydrochloride (1:1), (2s)- |
| 1-amino-3-chloro-2-propanol hydrochloride, (-)- |
| cl-88236 |
| 1-amino-3-chloro-2-propanol hydrochloride, (2s)- |
| CS-W021152 |
| (2s)-1-amino-3-chloropropan-2-ol hydrochloride (1:1) |
| (2s)-1-amino-3-chloro-propan-2-ol hydrochloride |
| AS-10252 |
| AMY31075 |
| Q27264905 |
| (2s)-1-amino-3-chloropropan-2-ol;hydrochloride |
| (s)-1-amino-3-chloro-2-propanol hcl |
| F14970 |
| (s)-1-amino-3-chloropropan-2-olhydrochloride |
| EN300-1717672 |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| "Male Wistar Strain rats of known fertility were given subcutaneous dosage of three drugs, alpha-chlorohydrin, amino-alpha-chlorohydrin, and busulphan alone or in combination for a period of thirty days." | ( Agonistic properties of low doses of antifertility compounds in male rats. Hafez, ES; Shandilya, LN; Snydle, FE, 1979) | 0.26 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||